Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors. Wang C, Tang H, Geng A, Dai B, et al. Proc Natl Acad Sci U S A 2020;117:26356-26365.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang C, Tang H, Geng A, Dai B, et al. Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors. Proc Natl Acad Sci U S A 2020;117:26356-26365.
PMID: 33020270